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Conization and healthcare use: a population-based
register study
Maria E. Frederiksena, Miguel Vázquez-Prada Bailleta, Pernille T. Jensenb,
Carsten Rygaardd, Jesper Hallasc and Elsebeth Lyngea
The aim of this study was to assess whether negative
psychological consequences of conization reported in
questionnaire studies translated into increased use of the
healthcare services that could relieve such symptoms. This
was a population-based register study comparing women
undergoing conization with a control group of women with
normal cytology results. Data were derived from Danish
registers. Using the difference-in-differences method, we
measured contacts with general practitioners (GPs),
hospitals, psychiatrist/psychologists, and use of anxiolytic
and antidepressant prescription drugs over 5 years ‘before’
and ‘after’ the conization in the study group, and in
comparable periods in the control group. During the ‘before’
period, women who later had a conization had greater
contact with GPs and hospitals, and slightly more contact
with psychiatrist/psychologists, than control women. In
both groups, healthcare use increased significantly from the
‘before’ to the ‘after’ period. For contacts with GPs and
hospitals, the increase was significantly larger for the
conization group than for the control group, but this could
be attributed to the standard postconization follow-up
process. In the ‘before’ period, women who later had a
conization used fewer drugs than women of the control-
group, but their drug use increased similarly over time. The
conization event did not result in an increased use of the
healthcare services that could relieve potential negative
side effects. However, women who underwent a conization
seemed to constitute a select group as they already used
GPs and hospitals more frequently, and anxiolytic and
antidepressant drugs less frequently, than other women in
the years ‘before’ the conization event. European Journal of
Cancer Prevention 00:000–000 Copyright © 2017 The
Author(s). Published by Wolters Kluwer Health, Inc.
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Introduction
Treatment of screen-detected cervical intraepithelial
neoplasia (CIN) has reduced the incidence of, and mor-
tality from, cervical cancer (International Agency for
Research on Cancer (IARC), 2005). CIN lesions can be
both progressive and nonprogressive, but there is currently
no method available to identify progression potential.
Therefore, treatment is normally recommended for all
cases of high-grade CIN (Andersen et al., 2001). Currently,
the most common treatment is large loop excision of the
transformation zone (LLETZ), which is also known as a
loop electrosurgical excision procedure. This is a minor
surgical procedure, typically performed in an outpatient
setting, and is highly effective in preventing progression to
cervical cancer.
In Denmark, with its high background risk of cervical
cancer, but an effective nationwide screening program,
14–16% of women have undergone CIN treatment dur-
ing their lifetime (Barken et al., 2012). This has led to a
decrease in the incidence of cervical cancer, but has also
resulted in an increased number of overtreatment cases
(Barken et al., 2012). Similar patterns have been observed
in other countries (Raffle et al., 2003).
LLETZ may cause minor, immediate side effects, such
as pain, discharge, and bleeding (Sharp et al., 2009).
Whether treatment may potentially lead to adverse
obstetric outcomes has been debated (Arbyn et al., 2008;
Bevis and Biggio, 2011). In Denmark, LLETZ has been
found to be associated with preterm delivery (Noehr
et al., 2009). Several studies have reported negative
psychological consequences when comparing women
undergoing LLETZ with other women (Frederiksen
et al., 2015). However, these studies all used psycho-
metric measurement, which might be prone to recall and
reporting biases. Furthermore, these studies only com-
pared the two groups of women following treatment,
which leaves them susceptible to considerations of
selection bias.
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Against this background, we carried out a population-based,
register study of the potential impact of LLETZ treatment
on women’s use of healthcare services. Our study included
all women undergoing LLETZ in Denmark between 2002
and 2005, and a control group of screened women. All data
on healthcare use were collected independently from the
LLETZ treatment data. To control for a potential selection
bias, we included data from the time periods ‘before’ and
‘after’ LLEZT treatment.
Materials and methods
Cervical cancer screening and conization in Denmark
In the 1960s, organized, population-based cervical screen-
ing started in parts of Denmark, and opportunistic screening
became widespread after 1969 (Lynge et al., 2006). The first
national guideline recommending the screening of women
aged between 23 and 59 years of age, every third year, was
issued in 1986. In 2007, a new guideline recommended
screening every third year for women aged 23–50 years, and
every fifth year for women aged 50–65 years. Human
papillomavirus (HPV) testing also became a recommenda-
tion for women older than the age of 30 years, as triage for
atypical squamous cell of undetermined significance, for
control after conization, and as a check-up test for women
aged 60–64 years (Sundhedsstyrelsen, 2012). Screening
coverage in Denmark is around 75% (DKLS, 2012).
In 2001, the first national guideline for CIN treatment
was established, and this guideline remained unchanged
throughout our study period. Treatment was recommended
if a cervical biopsy showed CIN2, CIN3 or persisting CIN1
for more than 12 months (Andersen et al., 2001). The
recommended treatment was colposcopy-guided LLETZ
excision of the transformation zone.
CIN treatment was performed either in hospitals (both in-
patient and outpatient) or in private gynecological clinics.
CIN treatment performed in hospitals was recorded
from operation codes in the National Patient Register
(Andersen et al., 2011). CIN treatment performed by pri-
vate gynecologists was recorded by payment codes in the
National Health Service Register (Prendiville, 1995).
Specimens from CIN treatment were recorded using
topography codes in the Danish Pathology Data Bank
(Patobank), which, during our study period, included
almost all specimens from both public and private sectors,
except from Copenhagen municipality, which was there-
fore excluded from our analysis (Pedersen, 2011). The
operation, payment, and topography codes used in the
three registers did not enable distinction between
LLETZ and cold-knife or laser conization, but from the
late 1990s, LLETZ became the preferred modality for
CIN treatment (Bjerregaard and Larsen, 2011). For con-
venience, we use the term ‘conization’ in this paper. From
a previous study, we know that destructive treatment and
hysterectomy constituted 16% of CIN treatment in the
relevant time period (Barken et al., 2012), and these CIN
patients were not included in this study.
Design
Our ‘exposed’ group included women registered in Denmark,
aged between 23 and 59 years, and having undergone their
first conization during the period 2002–2005. For each of these
women, we studied healthcare use during a 10-year period:
from 5 years before (‘before’ period) to 5 years after (‘after’
period) conization. The women had to have lived inDenmark
throughout this 10-year period.
The ‘non-exposed’ group of this study comprised all
women aged 23–59 years with a normal cytology result
between 2002 and 2005 and neither CIN nor cervical
cancer in the ‘before’ period. For each of these women,
we studied healthcare use during the 5 years before
(‘before’ period) and the 5 years after (‘after’ period) their
normal cytology result.
Contact with general practitioners (GPs) and psychiatrists/
psychologists (PSYs) was measured by the number of
contacts with patients. A contact could include a con-
sultation, telephone or e-mail consultation, referral to a
specialist or a hospital, renewal of a prescription, or a
home visit. Hospital use was measured by the number of
hospital contacts, including both in-patient and outpatient
procedures. Finally, we measured the use of painkillers or
anxiolytic and antidepressant prescription drugs by the
number of ‘defined daily dosages (DDDs)’ for drugs
defined by selected ‘Anatomical Therapeutic Chemical
classification’ (ATC) codes. DDD is the assumed daily
maintenance dose administered for the main indication
as monotherapy. We included opioids ATC N02A,
antiepileptic ATC N03, psycholeptic ATC N05,
psychoanaleptic ATC N06, and other nervous system
drugs ATC N07.
Other variables were age and region. Age was divided into
23–32, 33–43, and 43–59 year categories. Denmark was
divided into three regions: ‘Capital’ (Copenhagen and
Frederiksberg municipalities), ‘Islands’ (old Frederiksborg,
Roskilde, Vestsjælland, Storstrøm, Bornholm, and Fyn
counties), and ‘Jutland’ (old Sønderjylland, Ribe, Vejle,
Ringkøbing, Århus, Viborg, and Nordjylland counties).
Data sources
Data on conization were retrieved from the three registers
described above. Data on normal cytology results were
obtained from the Patobank. Data on date of birth and
residence in Denmark, during the 10-year study period,
were obtained from the Danish Civil Registration System
(Kildemoes et al., 2011). Data on contact with GPs and
psychologist/psychiatrist were retrieved from the National
Health Service Register. Data on hospital contact were
retrieved from the National Patient Register. Data on the
use of prescribed and purchased drugs were obtained from
the Danish National Prescription Registry (Christensen
et al., 2011). The data from these sources were linked
through each woman’s unique personal identification number,
which is assigned to all individuals with a permanent address
2 European Journal of Cancer Prevention 2017, Vol 00 No 00
in Denmark and used for identification in all registers. Data
were approved by the Danish Data Protection Agency.
Statistical analysis
Weused the difference-in-differencesmethod, where the data
provided four points of interest for each type of healthcare use:
number of contacts in the ‘before’ period for exposed women,
number of contacts in the ‘before’ period for nonexposed
women, number of contacts in the ‘after’ period for exposed
women, and number of contacts in the ‘after’ period for
nonexposed women. The aim of the analysis was to assess the
effect of exposure on the changes in the number of healthcare
interactions from the ‘before’ to the ‘after’ period.
General linear mixed models and least square means
were applied to the data, and the statistical significance of
the mean number of contacts for exposed and non-
exposed women, in the ‘before’ and ‘after’ periods, their
confidence intervals, and their statistical significance was
calculated. We also calculated the differences between
the ‘before’ and the ‘after’ period for exposed women and
for nonexposed women, their confidence intervals, and
statistical significance.
Secondary analyses, stratified by age and region, were
carried out using the same statistical model. These ana-
lyses were repeated using generalized linear mixed
models with different distributions and link functions
(e.g. Gaussian, Poisson, negative binomial), leading to
almost equivalent results. This analysis was carried out
using R, version 3.2.0 (The R foundation for Statistical
Computing, Vienna, Austria).
Results
In total, 14 957 women who underwent a conization and
923 094 who did not undergo a conization were included in
the study (Table 1). Approximately half, 52%, of the women
in the conization group were aged between 23 and 32 years,
and 43% of the women who did not undergo conization
were in the age group 43–59 years. These women were
distributed evenly across regions.
Around 40% of the women in both groups had 24–53
contacts with their GPs in both the ‘before’ and the ‘after’
periods (Table 1). The majority of women had no
hospital contact (56–69%), nor any contact with a PSYs
(88–93%). Just under half of the women had used at
least one of the drugs studied, and around 15% had used
260 or more DDDs.
Contact with general practitioners
Women with conization had a mean number of 62.2 contacts
with their GP in the ‘before’ period and 69.5 in the ‘after’
period, which represents a change of 7.29 [95% confidence
interval (CI): 6.63–7.94] (Fig. 1). Women without conization
had 54.7 GP contacts in the ‘before’ period and 61.1 in
the ‘after’ period, representing a change of 6.36 (95% CI:
6.28–6.45). Women with conization showed a greater increase
in their number of GP contacts over time, 0.93 more than
women without conization (P=0.006).
This pattern was observed in both the youngest
(23–32 years) and the eldest (43–59 years) age groups, and
in all regions. In the age group 33–42 years, the number of
contacts with GPs was stable for women with conization,
and slightly reduced for women without conization
(Supplementary File 1, Supplemental digital content 1,
http://links.lww.com/EJCP/A181).
Contact with hospitals
Women with conization had a mean number of 0.860 hospital
contacts in the ‘before’ period and 1.00 in the ‘after’ period,
which represented a change of 0.141 (95% CI: 0.120–0.163)
(Fig. 2). For women without conization, it was 0.613 ‘before’
and 0.688 ‘after’, representing a change of 0.075 (95% CI:
0.072–0.077). Women with conization increased their number
of hospital contacts 0.066 more than women without coniza-
tion (P<0,001).
In the youngest age group, 23–32 years, and in the eldest
age group, 43–59 years, and across all regions, the same
pattern emerged. In the 33–42 year age group, the number
of contacts with hospitals was stable for women with
Table 1 Distribution of study population by age and region at the
time of the event and by use of healthcare services
Women with conisation
(N=14 957) [n (%)]
Women without conisation
(N=923 094) [n (%)]
Age at event (years)
23–32 7757 (52) 250 105 (27)
33–42 4741 (32) 271 878 (30)
43–59 2459 (16) 401 111 (43)
Region at event
Capitala 4314 (29) 199794 (22)
Islandsb 3704 (25) 252 241 (27)
Jutland 6939 (46) 471 059 (51)
Before (%) After (%) Before (%) After (%)
Contacts to GP
0–23 2171 (15) 1594 (11) 217264 (23) 185 663 (20)
24–53 6008 (40) 5395 (36) 362 109 (39) 336 976 (37)
54–79 3324 (22) 3533 (24) 170 489 (18) 182 844 (19)
80+ 3454 (23) 4435 (29) 173 232 (20) 217611 (24)
Contact to hospital
0 8642 (58) 8416 (56) 635 419 (69) 630 077 (69)
1 3614 (24) 3252 (22) 165 066 (18) 157657 (17)
2 1341 (9) 1574 (11) 63 173 (7) 67 377 (7)
3+ 1360 (9) 1715 (11) 59 436 (6) 67 983 (7)
Contact with psychologist/psychiatrist
0 13 587 (91) 13 102 (88) 856 469 (93) 834757 (90)
1–4 510 (3) 573 (4) 21 237 (2) 25 246 (3)
5–9 365 (2) 478 (3) 17 547 (2) 22 739 (2)
10+ 495 (3) 804 (5) 27841 (3) 40 352 (5)
DDD of prescription drugs
0 9229 (62) 8009 (54) 552 057 (60) 484 220 (52)
1–59 3196 (21) 3069 (21) 177942 (19) 171 090 (19)
60–259 1037 (7) 1325 (9) 71 105 (8) 81 941 (9)
260+ 1505 (10) 2554 (16) 121 990 (13) 185 843 (20)
DDD, defined daily dosages; GP, general practitioner.
aCopenhagen and Frederiksberg municipalities.
bOld Copenhagen, Frederiksborg, Roskilde, Vestsjælland, Storstrøm, Bornholm,
and Fyn counties.
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conization and slightly decreased for women without
conization (Supplementary File 2, Supplemental digital
content 1, http://links.lww.com/EJCP/A181).
Contact with psychologists/psychiatrists
In the ‘before’ period, women with conization had a mean
number of contacts with PSYs of 0.913, which increased to
1.480 ‘after’, representing a change of 0.563 (95% CI:
0.477–0.649) (Fig. 3). Women without conization started out
with effectively the same mean number, 0.854, which
increased to 1.28 in the ‘after’ period, representing a differ-
ence of 0.423 (95% CI: 0.412–0.434). The increase over time
was thus slightly larger for women with conization than for
those without (P=0.01). This pattern was found across all
age and region groups (Supplementary File 3, Supplemental
digital content 1, http://links.lww.com/EJCP/A181).
Use of prescription drugs
Women with conization used 156.8 DDDs in the ‘before’
period and 313.2 DDDs ‘after’, yielding a difference of
156.5 (95% CI: 147.9–165.1). Women without conization
used 226.7 DDDs before and 383.0 DDD after, repre-
senting a difference of 156.3 (95% CI: 155.2–157.4)
(Fig. 4). This increase over time was similar across the
two groups (P= 0.958). When stratifying for age and
region, this pattern persisted for the youngest and eldest
age groups, but not for the 23–32 year age group, where
no significant difference was found between the two
groups of women (Supplementary File 4, Supplemental
digital content 1, http://links.lww.com/EJCP/A181).
Discussion
Main findings
This study investigated the association between conization
and healthcare use in a large, population-based register
study. Three important findings should be highlighted here
and will be discussed further below. First, there was a
selection effect, which was observed to be inconsistent
across the four studied types of healthcare services. In the
‘before’ period, women who later had a conization had more
Fig. 1
Contact to GP Mean (95% CI)
Women with 
conization:
Before
After 
Difference
62.2 (61.1-63.3)
69.5 (68.4-70.5)
7.29 (6.63-7.94)
Women with 
without conization:
Before
After 
Difference
54.7 (54.6-54.9)
61.1 (61.0-61.2)
6.36 (6.28-6.45)
Mean number of contacts to GP by period (before/after) and exposure (with/without) and mean of differences in number of contacts to GP from ‘after’
minus ‘before’ period by exposure.
Fig. 2
Contacts to 
hospital 
Mean (95% CI) 
Women with 
conization: 
Before 
After  
Difference 
0.860 (0.833-0.886) 
1.00 (0.975-1.027) 
0.141 (0.012-0.163)  
Women without 
conization: 
Before 
After  
Difference 
0.613 (0.610-0.617) 
0.688 (0.685-0.691) 
0.075 (0.072-0.077) 
Mean number of contacts with hospitals by period (before/after) and exposure (with/without) and mean differences in the number of admissions to
hospital from ‘after’ minus ‘before’ period by exposure. CI, confidence interval.
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contact with GPs and hospitals, and an almost similar
amount of contact with PSYs than women who later did not
undergo a conization procedure. However, surprisingly, for
drug use, the opposite pattern was observed as women who
later had a conization used significantly fewer anxiolytic and
antidepressant drugs in the ‘before’ period than women
who later did not undergo conization.
Second, an aging effect was present, where the use of
healthcare services increased from the ‘before’ to the
‘after’ period for all women, except for their contact with
GPs and hospitals for women aged 33–42 years who did
not have a conization. Finally, an apparent exposure
effect was present, where contact with GPs and hospitals
increased to a significantly greater extent from the
‘before’ to the ‘after’ period of women who underwent
conization in relation to women who did not. For contact
with PSYs, this exposure effect was borderline sig-
nificant, and for drug use it was absent. These observed
effects will be discussed in the following sections.
Are women who undergo conization a select group?
We found that women who underwent conization later in
life had already in the period ‘before’ their procedure had
more GP contacts than women who did not. All women who
undergo conization will, by definition, have had one extra
contact with their GP in the period leading up to their
procedure as they require a referral from the GP to the
treating gynecologist. Women with abnormalities that start
as an atypical squamous cell of undetermined significance/
low-grade squamous intraepithelial lesion and that result in
the need for a conization procedure may have had additional
1–2 GP contacts in the period ‘before’ conization, as part of
the diagnostic process, with repeated cytology required
before they are referred to a gynecologist. However, these
conization-related GP contacts cannot explain the additional
5.5 GP contacts in the exposed than in the nonexposed
group in the period ‘before’ conization. It therefore seems
reasonable to conclude that the women who later underwent
conization constituted a select group with above average GP
contact. The explanation for this selection effect is currently
Fig. 3
Contact to 
psychologist/
psychiatrist
Mean (95% CI)
Women with
conization:
Before
After
Difference
0.913 (0.800-1.025)  
1.48 (1.36-1.59) 
0.563 (0.477-0.649)
Women without
conization:
Before
After 
Difference
0.854 (0.840-0.869)
1.28 (1.26-1.29)
0.423 (0.412-0.434)
Mean number of contacts to psychologist/psychiatrist of by period (before/after) and exposure (with/without) and mean of differences in number of
contacts to psychologist/psychiatrist from‘after’ minus ‘before’ period by exposure.
Fig. 4
DDD of 
prescription 
drugs
Mean (95% CI)
Women with 
conization:
Before
After 
Difference
91.4 (75.9-107) 
176 (160.3-191)
84.38 (76.96-91.81)
Women without 
conization:
Before
After 
Difference
186 (184-188)
314 (312-316)
128.1 (127.2-129.1) 
Mean number of defined daily dosages (DDD) of prescription drugs by period (before/after) and exposure (with/without) and mean differences in
DDD of prescription drugs from ‘after’ minus ‘before’ period by exposure. CI, confidence interval.
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unknown. An in-depth study is required to identify the
clinical background for this extra interaction with healthcare
professionals.
Does conization increase the use of healthcare?
At least part of this greater increase in the number of GP
contacts over time, for exposed women compared with non-
exposed women, of 0.93, might be explained by postconiza-
tion follow-ups sometimes being performed by GPs. The
slightly, but statistically significant, greater increase in hospital
contacts for exposed women, in comparison with nonexposed
women, of 0.066 contacts, could also be because of post-
conization follow-ups being performed in the hospitals that
performed their procedures. It therefore seems reasonable to
conclude that conization did not increase contact with GPs
and hospitals beyond what could be explained reasonably by
postconization controls.
Women without conization
In terms of the use of prescription anxiolytic and anti-
depressant drugs, women without conization showed a higher
use in the ‘before’ period than women who underwent con-
ization later (Fig. 4). This pattern was unexpected. It could
be that women who used these drugs had less sexual activity
and therefore had a lower risk of developing precancer lesions.
A large, questionnaire-based study in Denmark showed
an increased risk of sexual dysfunction in women with poor
self-rated health, odds ratio: 1.91 (95% CI: 1.087–3.37), and
mental health problems, odds ratio: 2.59 (95% CI: 1.60–4.22)
(Christensen et al., 2011).
Strengths and limitations
By focusing on the use of healthcare, we were able to char-
acterize women undergoing conization and women having
normal cytology results both ‘before’ and ‘after’ these events
took place. This helped us to identify a possible selection
effect, which previous studies have failed to show. We used
population-based data from well-maintained Danish registers,
thus excluding reporting and recall biases, and ensuring
almost no loss of follow-up.
Limitations included the inability to separate LLETZ
from other conization modalities, and the fact the around
16–23% of CIN treatments in 2002–2005 were performed
by procedures other than conization (Barken et al., 2012).
Interpretations
Psychological outcomes following CIN diagnosis or
treatment have been studied extensively by psycho-
metric measurement. Our previous review (Frederiksen
et al., 2015) showed that in these studies, a CIN diagnosis
and/or CIN treatment had consistently been associated
with a negative psychological impact.
No other study has investigated the impact of conization
on women’ healthcare usage. It is, however, reasonable to
expect that psychological problems will lead to the use of
healthcare. In Denmark, where access to the GP is free of
charge, about one-third of all contacts with GPs concern
psychological disorders, and an even greater proportion of
contacts is related to emotional problems (Davidsen, 2008).
In terms of our data from the period ‘after’ conization, these
were in line with results from studies based on psychometric
measurement. We found that women in the conization
group were more intensive users of healthcare services, apart
from the use of anxiolytic and antidepressive drugs, than
women who did not undergo conization. However, taking
into account our data from the period ‘before’ conization, our
study indicated that the difference between the two groups
of women derived from a selection effect rather than from
exposure to conization itself.
On the basis of our results, we recommend that a possible
selection effect should be considered in the handling
of women with psychological problems that follow a
conization procedure. This selection effect could indicate
that the psychological problems derive not from the
conization itself, but from other problems encountered
by this group of patients. Therefore, a woman’s reaction
to conization should ideally be seen in light of her general
medical history.
In generations of women HPV-vaccinated before sexual
debut, the frequency of high-grade CIN lesions is expected
to reduce to one half of current levels (Hestbech et al., 2015).
Another way of reducing the number of conization proce-
dures required may be to reduce the risk of HPV reinfection
by male partners using condoms for a certain period of
time (Hogewoning et al., 2003; Munk et al., 2012a, 2012b).
Nevertheless, women undergoing conization will, for years
to come, remain a large group for whom adequate care is
needed. In the provision of this care, a woman’s medical
history before conization should also be taken into account.
Conclusion
This study was carried out to investigate whether the
negative psychological consequences of conization reported
by questionnaire studies, etc. translated into an increased
use of the healthcare services that could be used to relieve
such symptoms. Our study showed this not to be the case.
However, women who underwent conization had sig-
nificantly more contact with their GPs and hospitals than
women who did not undergo conization, even ‘before’ the
event. This indicates that, in treating women with psycho-
logical problems, following a conization procedure, their
medical history over the period before conization should
also be taken into account.
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